First patients enrolled in Cromos Pharma managed Covid-19 trial

27 April 2020
Cromos Pharma is proud to be part of the global search for effective COVID-19 treatments. Today we are pleased to announce the enrollment of the first patients in clinical trials designed to be find drugs to treat the symptoms of coronavirus.

"We are honored and humbled to have been enlisted to run clinical trials aimed at finding effective treatments for the symptoms of COVID-19. We are pleased to be able to put our experience and expertise in managing clinical trials to work in the efforts to defeat this pandemic", says Dr Vlad Bogin, CEO.

Find out more about Cromos Pharma's efforts in the fight against COVID-19 here.
Back to the news